• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缀合物药物递送系统的研究进展:机遇与挑战。

Advances in conjugate drug delivery System: Opportunities and challenges.

机构信息

College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, PuZhuNanLu No.30, Nanjing 211816, Jiangsu Province, China.

College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, PuZhuNanLu No.30, Nanjing 211816, Jiangsu Province, China.

出版信息

Int J Pharm. 2024 Dec 25;667(Pt A):124867. doi: 10.1016/j.ijpharm.2024.124867. Epub 2024 Oct 24.

DOI:10.1016/j.ijpharm.2024.124867
PMID:39454974
Abstract

Ideal drug delivery system is designed to accurately deliver the drug to its intended site. The development of conjugate drug delivery system introduces a novel pathway to precise drug delivery with advantages over traditional methods. The core of a conjugate drug delivery system comprises a molecule with two functional components, bounded by a linker structure. One component is responsible for delivering or stabilizing the conjugate, while the other is used to provide the therapeutic or diagnostic effects of the bioactivity. Conjugate drug delivery system improves patient health by maintaining the structural stability of drugs in molecular form, delivering therapeutics or diagnostic material to the target site, minimising off-target accumulation and promoting patient compliance. This system includes various types of drug conjugates that modulate drug pharmacokinetics, stability, absorption, and exposure in lesions and healthy tissues. In this review, we focus on the key characteristics and recent advances of various conjugate drug delivery systems and explore their mechanisms. We also point out the current challenges faced by conjugate drug delivery system and look forward to the future prospects.

摘要

理想的药物传递系统旨在将药物精确递送到其预期的部位。结合药物传递系统的发展为精确药物传递引入了一种新途径,其具有优于传统方法的优势。结合药物传递系统的核心由两个功能组件的分子组成,通过连接体结构连接。一个组件负责传递或稳定结合物,而另一个组件用于提供生物活性的治疗或诊断效果。结合药物传递系统通过保持药物在分子形式下的结构稳定性,将治疗剂或诊断材料递送到靶位,减少非靶位的积累,提高患者的顺应性,从而改善患者的健康状况。该系统包括各种类型的药物结合物,可调节药物的药代动力学、稳定性、吸收和在病变和健康组织中的暴露。在这篇综述中,我们重点介绍了各种结合药物传递系统的关键特征和最新进展,并探讨了它们的作用机制。我们还指出了结合药物传递系统目前面临的挑战,并展望了未来的前景。

相似文献

1
Advances in conjugate drug delivery System: Opportunities and challenges.缀合物药物递送系统的研究进展:机遇与挑战。
Int J Pharm. 2024 Dec 25;667(Pt A):124867. doi: 10.1016/j.ijpharm.2024.124867. Epub 2024 Oct 24.
2
Polymer-drug conjugate therapeutics: advances, insights and prospects.聚合物-药物偶联物治疗学:进展、见解与展望。
Nat Rev Drug Discov. 2019 Apr;18(4):273-294. doi: 10.1038/s41573-018-0005-0.
3
Peptide-drug conjugate-based novel molecular drug delivery system in cancer.基于肽药物偶联物的新型分子药物递送系统在癌症中的应用。
Trends Pharmacol Sci. 2021 Oct;42(10):857-869. doi: 10.1016/j.tips.2021.07.001. Epub 2021 Jul 30.
4
Recent advances in drug delivery: potential and limitations of carbon nanotubes.药物递送的最新进展:碳纳米管的潜力与局限性
Recent Pat Drug Deliv Formul. 2007;1(3):214-21. doi: 10.2174/187221107782331601.
5
Recent developments and patenting of lipoprotein based formulations.基于脂蛋白制剂的最新进展与专利情况
Recent Pat Drug Deliv Formul. 2007;1(2):143-5. doi: 10.2174/187221107780831914.
6
Poly - (l) - glutamic acid drug delivery system for the intravesical therapy of bladder cancer using WGA as targeting moiety.以WGA为靶向部分的聚(L)-谷氨酸药物递送系统用于膀胱癌的膀胱内治疗。
Eur J Pharm Biopharm. 2017 Jun;115:131-139. doi: 10.1016/j.ejpb.2017.02.016. Epub 2017 Feb 22.
7
Rapidly disintegrating oramucosal drug delivery technologies.快速崩解口腔黏膜给药技术。
Pharm Dev Technol. 2009;14(6):588-601. doi: 10.3109/10837450902838700.
8
Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.固体脂质基质介导的纳米构建策略提高药物的口服生物利用度。
Expert Opin Drug Metab Toxicol. 2019 Jun;15(6):499-515. doi: 10.1080/17425255.2019.1621289. Epub 2019 May 29.
9
Drug conjugate-based anticancer therapy - Current status and perspectives.基于药物偶联物的抗癌疗法——现状与展望。
Cancer Lett. 2023 Jan 1;552:215969. doi: 10.1016/j.canlet.2022.215969. Epub 2022 Oct 22.
10
pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.用于口服给药的pH响应型载体:当前平台面临的挑战与机遇
Drug Deliv. 2017 Nov;24(1):569-581. doi: 10.1080/10717544.2017.1279238.

引用本文的文献

1
Bioactive Chalcone-Loaded Mesoporous Silica KIT-6 Nanocarrier: A Promising Strategy for Inflammation and Pain Management in Zebrafish.载有生物活性查尔酮的介孔二氧化硅KIT-6纳米载体:斑马鱼炎症和疼痛管理的一种有前景的策略。
Pharmaceutics. 2025 Jul 30;17(8):981. doi: 10.3390/pharmaceutics17080981.
2
Vitamin D3-Coated Surfaces and Their Role in Bone Repair and Peri-Implant Biomechanics.维生素D3涂层表面及其在骨修复和种植体周围生物力学中的作用。
Biology (Basel). 2025 Apr 26;14(5):476. doi: 10.3390/biology14050476.
3
Crosstalk between ferroptosis and endoplasmic reticulum stress: A potential target for ovarian cancer therapy (Review).
铁死亡与内质网应激之间的相互作用:卵巢癌治疗的潜在靶点(综述)
Int J Mol Med. 2025 Jun;55(6). doi: 10.3892/ijmm.2025.5538. Epub 2025 May 2.